Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson’s disease
The research sets the stage for potential <i>in vivo</i> evaluations and new strategies for managing PD, offering hope for improved treatments based on DA and not derivatives.
Authors
- María del Carmen Cárdenas‐Aguayo (ORCID: https://orcid.org/0000-0001-9156-2161)
- Juan Navarrete‐Bolaños
- Evelyn Y. Calvillo-Muñoz (ORCID: https://orcid.org/0000-0001-6261-7186)
- Francisco J. Padilla-Godínez (ORCID: https://orcid.org/0000-0002-9253-2463)
- Omar Collazo-Navarrete (ORCID: https://orcid.org/0000-0003-3405-2514)
- Myrian Velasco (ORCID: https://orcid.org/0000-0002-9276-1928)
- T. López (ORCID: https://orcid.org/0000-0002-6048-0419)
- Magdalena Guerra‐Crespo
- Mayra Angélica Alvarez Lemus (ORCID: https://orcid.org/0000-0002-4883-7067)
- Obed R. Lora-Marín
Institutions
- Universidad Autónoma Metropolitana (MX)
- Tecnológico Nacional de México (MX)
- Mexican Institute of Petroleum (MX)
- Instituto Politécnico Nacional (MX)
- National Polytechnic School (EC)
- Universidad Nacional Autónoma de México (MX)
- Universidad Juárez Autónoma de Tabasco (MX)
Publication Details
- Journal
- Nanomedicine
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1080/17435889.2025.2460228
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00